Tigran Harutyunyan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Tigran Harutyunyan has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Galina Hovhannisyan
Yerevan State University
12 shared publications - Rouben Aroutiounian
Laboratory of General and Molecular Genetics, RI Biology, Faculty of Biology, Yerevan State University, 8 Charents Str., Yerevan 0025, Armenia
11 shared publications - Thomas Liehr
Institute of Human Genetics, Jena University Hospital, Friedrich Schiller University, Jena, Germany
10 shared publications - Anzhela Sargsyan
Research Institute of Biology Yerevan State University, Alex Manoogian Yerevan Armenia
6 shared publications - Lily Kalashyan
Laboratory of General and Molecular Genetics, Research Institute of Biology, Yerevan State University, Alex Manoogian 1, Yerevan 0025, Armenia
3 shared publications Rouben Aroutiounian
3 shared publications
Latest Publications
- 31 October 2026
- Published by Elsevier in Microbial Pathogenesis
Analysis of antiviral effects of anti-EGFR DNA aptamers against African swine fever virus in Vero cells
- 31 October 2026
- Published by Elsevier in Microbial Pathogenesis
Analysis of antiviral effects of anti-EGFR DNA aptamers against African swine fever virus in Vero cells
- 14 February 2026
- Published by Springer Nature
- p. 417-423
Comet-FISH
- 14 February 2026
- Published by Springer Nature
- p. 425-430
Micronucleus FISH
- Open Access
- 21 October 2025
- Published by Yerevan State University in Journal of Innovative Solutions for Eco-Environmental Sustainability
- p. 078
8-OHdG Elevation in Hypoxic COVID-19: A Potential Link to Inflammation and Disease Severity
Background: Oxidative stress is increasingly recognized as a contributor to severe COVID-19, particularly in patients with hypoxemia and systemic inflammation. 8-hydroxy-2′-deoxyguanosine (8-OHdG) is a sensitive biomarker of oxidative DNA damage. However, its relevance to COVID-19 severity, particularly in relation to oxygen saturation and inflammatory markers, remains underexplored. Aim: This study aimed to evaluate 8-OHdG levels in blood plasma of COVID-19 patients using ELISA. Correlations between 8-OHdG and inflammatory markers C-reactive protein (CRP) and D-dimer were also analyzed. Methods: Plasma 8-OHdG (ng/mL) was measured by ELISA in hospitalized COVID-19 patients stratified into two groups based on peripheral oxygen saturation (SpO₂): hypoxic (SpO₂ 94%, n=32). CRP (mg/L) and D-dimer (μg/mL) levels were recorded on admission. Results: 8-OHdG levels were significantly higher in hypoxic patients (1.48 ± 0.10 ng/mL) than in normoxic group (1.20 ± 0.05 ng/mL). CRP (105.16 ± 12.57 mg/L) and D-dimer (9.95 ± 1.11 μg/mL) were also elevated in hypoxic patients compared to normoxic group (65.63 ± 11.40 mg/L and 5.46 ± 1.27 μg/mL, respectively). Spearman’s correlation analysis showed strong positive correlations between 8-OHdG and both CRP and D-dimer in normoxic (r = 0.872 and 0.764) and hypoxic (r = 0.850 and 0.901) groups. Conclusions: Increased 8-OHdG levels and its strong correlations with CRP and D-dimer suggest that 8-OHdG may serve as a potential biomarker for identifying patients at greater risk of oxidative injury and poor outcomes. Further research is needed to clarify its prognostic role and integration into clinical risk assessment.
- 21 October 2025
- Published by Yerevan State University in Journal of Innovative Solutions for Eco-Environmental Sustainability
- p. 078
Open Access8-OHdG Elevation in Hypoxic COVID-19: A Potential Link to Inflammation and Disease Severity
Background: Oxidative stress is increasingly recognized as a contributor to severe COVID-19, particularly in patients with hypoxemia and systemic inflammation. 8-hydroxy-2′-deoxyguanosine (8-OHdG) is a sensitive biomarker of oxidative DNA damage. However, its relevance to COVID-19 severity, particularly in relation to oxygen saturation and inflammatory markers, remains underexplored. Aim: This study aimed to evaluate 8-OHdG levels in blood plasma of COVID-19 patients using ELISA. Correlations between 8-OHdG and inflammatory markers C-reactive protein (CRP) and D-dimer were also analyzed. Methods: Plasma 8-OHdG (ng/mL) was measured by ELISA in hospitalized COVID-19 patients stratified into two groups based on peripheral oxygen saturation (SpO₂): hypoxic (SpO₂ 94%, n=32). CRP (mg/L) and D-dimer (μg/mL) levels were recorded on admission. Results: 8-OHdG levels were significantly higher in hypoxic patients (1.48 ± 0.10 ng/mL) than in normoxic group (1.20 ± 0.05 ng/mL). CRP (105.16 ± 12.57 mg/L) and D-dimer (9.95 ± 1.11 μg/mL) were also elevated in hypoxic patients compared to normoxic group (65.63 ± 11.40 mg/L and 5.46 ± 1.27 μg/mL, respectively). Spearman’s correlation analysis showed strong positive correlations between 8-OHdG and both CRP and D-dimer in normoxic (r = 0.872 and 0.764) and hypoxic (r = 0.850 and 0.901) groups. Conclusions: Increased 8-OHdG levels and its strong correlations with CRP and D-dimer suggest that 8-OHdG may serve as a potential biomarker for identifying patients at greater risk of oxidative injury and poor outcomes. Further research is needed to clarify its prognostic role and integration into clinical risk assessment.
- Open Access
- 3 April 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20  (4) , e0303736
Elucidating the impact of Hypericum alpestre extract and L-NAME on the PI3K/Akt signaling pathway in A549 lung adenocarcinoma and MDA-MB-231 triple-negative breast cancer cells
Plants of the Hypericaceae family have been traditionally used for their medicinal properties, including antibacterial, antiviral, and antioxidant activities. Among these, Hypericum alpestre (HA) extracts have shown notable cytotoxicity against various cancer cell lines, drawing attention to their phenolic compounds as potential anticancer agents. Similarly, N(G)-Nitro-L-arginine methyl ester (L-NAME), an inhibitor of nitric oxide synthase (NOS) activity, has emerged as a promising candidate in cancer therapy. However, the precise molecular mechanisms underlying the anticancer effects of both HA and L-NAME remain unclear. This study aimed to clarify the impact of HA and L-NAME on the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt)/ mammalian target of rapamycin (mTOR) signaling pathway in A549 human lung adenocarcinoma and MDA-MB-231 breast cancer triple-negative cells, with particular emphasis on the tumor necrosis factor-alpha (TNFα)/cyclooxygenase-2 (COX-2) and vascular endothelial growth factor A (VEGFα)/matrix metalloproteinase-2 (MMP-2) pathways. In silico analyses identified compounds within HA extracts with the highest affinity for PI3K/Akt, a finding subsequently confirmed by in vitro experiments. Notably, the combination of HA and L-NAME demonstrated greater efficacy than the combination of HA and 5-fluorouracil (5-FU), as evidenced by enhanced apoptotic activity. Both HA alone and in combination with L-NAME inhibited the TNFα/COX-2 and VEGFα/MMP-2 pathways. These results suggest that the therapeutic effects of HA, especially in combination with L-NAME, may be mediated through the PI3K/Akt signaling pathway. A better understanding of the interaction between HA polyphenols and PI3K/Akt signaling could pave the way for novel therapeutic strategies against cancer, including drug-resistant tumors.
- 3 April 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20  (4) , e0303736
Open AccessElucidating the impact of Hypericum alpestre extract and L-NAME on the PI3K/Akt signaling pathway in A549 lung adenocarcinoma and MDA-MB-231 triple-negative breast cancer cells
Plants of the Hypericaceae family have been traditionally used for their medicinal properties, including antibacterial, antiviral, and antioxidant activities. Among these, Hypericum alpestre (HA) extracts have shown notable cytotoxicity against various cancer cell lines, drawing attention to their phenolic compounds as potential anticancer agents. Similarly, N(G)-Nitro-L-arginine methyl ester (L-NAME), an inhibitor of nitric oxide synthase (NOS) activity, has emerged as a promising candidate in cancer therapy. However, the precise molecular mechanisms underlying the anticancer effects of both HA and L-NAME remain unclear. This study aimed to clarify the impact of HA and L-NAME on the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt)/ mammalian target of rapamycin (mTOR) signaling pathway in A549 human lung adenocarcinoma and MDA-MB-231 breast cancer triple-negative cells, with particular emphasis on the tumor necrosis factor-alpha (TNFα)/cyclooxygenase-2 (COX-2) and vascular endothelial growth factor A (VEGFα)/matrix metalloproteinase-2 (MMP-2) pathways. In silico analyses identified compounds within HA extracts with the highest affinity for PI3K/Akt, a finding subsequently confirmed by in vitro experiments. Notably, the combination of HA and L-NAME demonstrated greater efficacy than the combination of HA and 5-fluorouracil (5-FU), as evidenced by enhanced apoptotic activity. Both HA alone and in combination with L-NAME inhibited the TNFα/COX-2 and VEGFα/MMP-2 pathways. These results suggest that the therapeutic effects of HA, especially in combination with L-NAME, may be mediated through the PI3K/Akt signaling pathway. A better understanding of the interaction between HA polyphenols and PI3K/Akt signaling could pave the way for novel therapeutic strategies against cancer, including drug-resistant tumors.
- Open Access
- 24 September 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25  (19) , 10293
DNA Damage in Moderate and Severe COVID-19 Cases: Relation to Demographic, Clinical, and Laboratory Parameters
The ability of the SARS-CoV-2 virus to cause DNA damage in infected humans requires its study as a potential indicator of COVID-19 progression. DNA damage was studied in leukocytes of 65 COVID-19 patients stratified by sex, age, and disease severity in relation to demographic, clinical, and laboratory parameters. In a combined group of COVID-19 patients, DNA damage was shown to be elevated compared to controls (12.44% vs. 5.09%, p < 0.05). Severe cases showed higher DNA damage than moderate cases (14.66% vs. 10.65%, p < 0.05), and males displayed more damage than females (13.45% vs. 8.15%, p < 0.05). DNA damage is also correlated with international normalized ratio (INR) (r = 0.471, p < 0.001) and creatinine (r = 0.326, p < 0.05). In addition to DNA damage, severe COVID-19 is associated with age, C-reactive protein (CRP), and creatinine. Receiver operating characteristic analysis identified age, INR, creatinine, DNA damage, and CRP as significant predictors of disease severity, with cut-off values of 72.50 years, 1.46 s, 78.0 µmol/L, 9.72%, and 50.0 mg/L, respectively. The results show that DNA damage correlates with commonly accepted COVID-19 risk factors. These findings underscore the potential of DNA damage as a biomarker for COVID-19 severity, suggesting its inclusion in prognostic assessments to facilitate early intervention and improve patient outcomes.
- 24 September 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25  (19) , 10293
Open AccessDNA Damage in Moderate and Severe COVID-19 Cases: Relation to Demographic, Clinical, and Laboratory Parameters
The ability of the SARS-CoV-2 virus to cause DNA damage in infected humans requires its study as a potential indicator of COVID-19 progression. DNA damage was studied in leukocytes of 65 COVID-19 patients stratified by sex, age, and disease severity in relation to demographic, clinical, and laboratory parameters. In a combined group of COVID-19 patients, DNA damage was shown to be elevated compared to controls (12.44% vs. 5.09%, p < 0.05). Severe cases showed higher DNA damage than moderate cases (14.66% vs. 10.65%, p < 0.05), and males displayed more damage than females (13.45% vs. 8.15%, p < 0.05). DNA damage is also correlated with international normalized ratio (INR) (r = 0.471, p < 0.001) and creatinine (r = 0.326, p < 0.05). In addition to DNA damage, severe COVID-19 is associated with age, C-reactive protein (CRP), and creatinine. Receiver operating characteristic analysis identified age, INR, creatinine, DNA damage, and CRP as significant predictors of disease severity, with cut-off values of 72.50 years, 1.46 s, 78.0 µmol/L, 9.72%, and 50.0 mg/L, respectively. The results show that DNA damage correlates with commonly accepted COVID-19 risk factors. These findings underscore the potential of DNA damage as a biomarker for COVID-19 severity, suggesting its inclusion in prognostic assessments to facilitate early intervention and improve patient outcomes.
- 5 September 2024
- Published by Elsevier in Surfaces and Interfaces
- Vol. 53
Enhancing virus inhibition in track-etched membranes through surface modification with silver nanoparticles and curcumin
- 5 September 2024
- Published by Elsevier in Surfaces and Interfaces
- Vol. 53
Enhancing virus inhibition in track-etched membranes through surface modification with silver nanoparticles and curcumin
- Open Access
- 18 June 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25  (12) , 6709
Changes in Telomere Length in Leukocytes and Leukemic Cells after Ultrashort Electron Beam Radiation
Application of laser-generated electron beams in radiotherapy is a recent development. Accordingly, mechanisms of biological response to radiation damage need to be investigated. In this study, telomere length (TL) as endpoint of genetic damage was analyzed in human blood cells (leukocytes) and K562 leukemic cells irradiated with laser-generated ultrashort electron beam. Metaphases and interphases were analyzed in quantitative fluorescence in situ hybridization (Q-FISH) to assess TL. TLs were shortened compared to non-irradiated controls in both settings (metaphase and interphase) after irradiation with 0.5, 1.5, and 3.0 Gy in blood leukocytes. Radiation also caused a significant TL shortening detectable in the interphase of K562 cells. Overall, a negative correlation between TL and radiation doses was observed in normal and leukemic cells in a dose-dependent manner. K562 cells were more sensitive than normal blood cells to increasing doses of ultrashort electron beam radiation. As telomere shortening leads to genome instability and cell death, the results obtained confirm the suitability of this biomarker for assessing genotoxic effects of accelerated electrons for their further use in radiation therapy. Observed differences in TL shortening between normal and K562 cells provide an opportunity for further development of optimal radiation parameters to reduce side effects in normal cells during radiotherapy.
- 18 June 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25  (12) , 6709
Open AccessChanges in Telomere Length in Leukocytes and Leukemic Cells after Ultrashort Electron Beam Radiation
Application of laser-generated electron beams in radiotherapy is a recent development. Accordingly, mechanisms of biological response to radiation damage need to be investigated. In this study, telomere length (TL) as endpoint of genetic damage was analyzed in human blood cells (leukocytes) and K562 leukemic cells irradiated with laser-generated ultrashort electron beam. Metaphases and interphases were analyzed in quantitative fluorescence in situ hybridization (Q-FISH) to assess TL. TLs were shortened compared to non-irradiated controls in both settings (metaphase and interphase) after irradiation with 0.5, 1.5, and 3.0 Gy in blood leukocytes. Radiation also caused a significant TL shortening detectable in the interphase of K562 cells. Overall, a negative correlation between TL and radiation doses was observed in normal and leukemic cells in a dose-dependent manner. K562 cells were more sensitive than normal blood cells to increasing doses of ultrashort electron beam radiation. As telomere shortening leads to genome instability and cell death, the results obtained confirm the suitability of this biomarker for assessing genotoxic effects of accelerated electrons for their further use in radiation therapy. Observed differences in TL shortening between normal and K562 cells provide an opportunity for further development of optimal radiation parameters to reduce side effects in normal cells during radiotherapy.
- Open Access
Elucidating the Impact of Hypericum alpestre Extract and L-NAME on the PI3K/Akt Signaling Pathway in A549 Lung Adenocarcinoma Cells
Plants within the Hypericaceae family have been traditionally used for their medicinal properties, showcasing a wide range of effects such as antibacterial, antiviral, and antioxidant qualities. Hypericum alpestre (HA) extracts have exhibited significant cytotoxicity against various cancer cell lines. The phenolic compounds found in HA extracts have attracted attention for their potential in cancer prevention. L-NAME, known for its ability to inhibit nitric oxide synthase (NOS) activity, has emerged as a promising approach in cancer therapy. However, the precise molecular mechanisms underlying the anticancer effects of HA and L-NAME remain unclear. This study aims to clarify the impact of HA and L-NAME on the PI3K/Akt signaling pathway in A549 lung adenocarcinoma cells, with a specific focus on TNFa/COX-2 and VEGFa/MMP-2 pathways. In silico analysis, they identified the compounds with the highest affinity for PI3K/Akt, a finding validated by subsequent in vitro experiments. Furthermore, the combination of herbs and L-NAME exhibited superior efficacy compared to the herb and 5-FU combination, as evidenced by the promotion of apoptosis. Both the herb alone and the combination of the herb with L-NAME demonstrated inhibitory effects on the TNFa/COX-2 and VEGFa/MMP-2 pathways. This therapeutic approach is hypothesized to operate through the PI3k/Akt cell signaling pathway. A better understanding of the interaction between HA polyphenols and PI3K/Akt signaling could pave the way for novel therapeutic strategies against cancer, including drug-resistant tumors.
Open AccessElucidating the Impact of Hypericum alpestre Extract and L-NAME on the PI3K/Akt Signaling Pathway in A549 Lung Adenocarcinoma Cells
Plants within the Hypericaceae family have been traditionally used for their medicinal properties, showcasing a wide range of effects such as antibacterial, antiviral, and antioxidant qualities. Hypericum alpestre (HA) extracts have exhibited significant cytotoxicity against various cancer cell lines. The phenolic compounds found in HA extracts have attracted attention for their potential in cancer prevention. L-NAME, known for its ability to inhibit nitric oxide synthase (NOS) activity, has emerged as a promising approach in cancer therapy. However, the precise molecular mechanisms underlying the anticancer effects of HA and L-NAME remain unclear. This study aims to clarify the impact of HA and L-NAME on the PI3K/Akt signaling pathway in A549 lung adenocarcinoma cells, with a specific focus on TNFa/COX-2 and VEGFa/MMP-2 pathways. In silico analysis, they identified the compounds with the highest affinity for PI3K/Akt, a finding validated by subsequent in vitro experiments. Furthermore, the combination of herbs and L-NAME exhibited superior efficacy compared to the herb and 5-FU combination, as evidenced by the promotion of apoptosis. Both the herb alone and the combination of the herb with L-NAME demonstrated inhibitory effects on the TNFa/COX-2 and VEGFa/MMP-2 pathways. This therapeutic approach is hypothesized to operate through the PI3k/Akt cell signaling pathway. A better understanding of the interaction between HA polyphenols and PI3K/Akt signaling could pave the way for novel therapeutic strategies against cancer, including drug-resistant tumors.
- Open Access
- 24 April 2024
- Published by Yerevan State University in Proceedings of the YSU B: Chemical and Biological Sciences
- Vol. 58  (1 (263)) , 9-16
CELL-FREE MITOCHONDRIAL DNA IN DOXORUBICIN-TREATED KCL22 AND K562 CELL LINES
Cell-free mitochondrial DNA (cf-mtDNA) is widely used as a biomarker of pathological processes, but its application for assessing the effects of environmental factors is limited. For the first time, cf-mtDNA was identified in the KCL22 cell culture treated with doxorubicin, which is known for its ability to disrupt mitochondrial functions. The results obtained indicate the effectiveness of using cf-mtDNA as a biomarker of genotoxic and cytotoxic effects.
- 24 April 2024
- Published by Yerevan State University in Proceedings of the YSU B: Chemical and Biological Sciences
- Vol. 58  (1 (263)) , 9-16
Open AccessCELL-FREE MITOCHONDRIAL DNA IN DOXORUBICIN-TREATED KCL22 AND K562 CELL LINES
Cell-free mitochondrial DNA (cf-mtDNA) is widely used as a biomarker of pathological processes, but its application for assessing the effects of environmental factors is limited. For the first time, cf-mtDNA was identified in the KCL22 cell culture treated with doxorubicin, which is known for its ability to disrupt mitochondrial functions. The results obtained indicate the effectiveness of using cf-mtDNA as a biomarker of genotoxic and cytotoxic effects.